sb 203580 has been researched along with l-779,450 in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (l-779,450) | Trials (l-779,450) | Recent Studies (post-2010) (l-779,450) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 15 | 0 | 11 |
| Protein | Taxonomy | sb 203580 (IC50) | l-779,450 (IC50) |
|---|---|---|---|
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | 0.0014 | |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | 0.01 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YD; Jiao, Y; Li, HF; Lu, T; Wang, X; Zhang, LY; Zhu, T | 1 |
1 other study(ies) available for sb 203580 and l-779,450
| Article | Year |
|---|---|
Pharmacophore identification of Raf-1 kinase inhibitors.
Topics: Binding Sites; Biological Transport; Enzyme Inhibitors; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Models, Biological; Models, Chemical; Proto-Oncogene Proteins c-raf; Structure-Activity Relationship | 2008 |